Patent · US Active

Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition

US8597904B2 · kind B2 · utility

0Cited by

1References

7Claims

0Family size

Assignee

Pono Corporation · US

Inventors

Andre Bachmann · Grand Rapids, US
Robert Dudler · Uster, CH
Michael Groll · Munich, DE

Key dates

Filing date	Nov 14, 2008
Grant date	Dec 3, 2013
Priority date	—
Expiry date	Jul 4, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention disclosed herein generally relates to methods and compositions for inhibiting proteasome activity comprising a syrbactin compound have the structure of Formula (I) or (II).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.